293 related articles for article (PubMed ID: 27988387)
1. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
[TBL] [Abstract][Full Text] [Related]
2. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
3. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
4. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein
Chen Y; Zhao X; Wu H
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1911-1924. PubMed ID: 31462094
[TBL] [Abstract][Full Text] [Related]
6. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
Chatham JC; Nöt LG; Fülöp N; Marchase RB
Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
[TBL] [Abstract][Full Text] [Related]
7. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
Marsh SA; Dell'Italia LJ; Chatham JC
Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
[TBL] [Abstract][Full Text] [Related]
8. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
9. Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose.
Ducheix S; Magré J; Cariou B; Prieur X
Front Endocrinol (Lausanne); 2018; 9():642. PubMed ID: 30420836
[TBL] [Abstract][Full Text] [Related]
10. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.
Fülöp N; Marchase RB; Chatham JC
Cardiovasc Res; 2007 Jan; 73(2):288-97. PubMed ID: 16970929
[TBL] [Abstract][Full Text] [Related]
11. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation, an original modulator of contractile activity in striated muscle.
Cieniewski-Bernard C; Montel V; Stevens L; Bastide B
J Muscle Res Cell Motil; 2009 Dec; 30(7-8):281-7. PubMed ID: 20182775
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes.
Akimoto Y; Hart GW; Hirano H; Kawakami H
Med Mol Morphol; 2005 Jun; 38(2):84-91. PubMed ID: 15944815
[TBL] [Abstract][Full Text] [Related]
14. Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.
Chatham JC; Young ME; Zhang J
Curr Opin Pharmacol; 2021 Apr; 57():1-12. PubMed ID: 32937226
[TBL] [Abstract][Full Text] [Related]
15. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.
Liu J; Pang Y; Chang T; Bounelis P; Chatham JC; Marchase RB
J Mol Cell Cardiol; 2006 Feb; 40(2):303-12. PubMed ID: 16337959
[TBL] [Abstract][Full Text] [Related]
16. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.
Liu J; Marchase RB; Chatham JC
J Mol Cell Cardiol; 2007 Jan; 42(1):177-85. PubMed ID: 17069847
[TBL] [Abstract][Full Text] [Related]
17. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.
Fricovsky ES; Suarez J; Ihm SH; Scott BT; Suarez-Ramirez JA; Banerjee I; Torres-Gonzalez M; Wang H; Ellrott I; Maya-Ramos L; Villarreal F; Dillmann WH
Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(7):R689-99. PubMed ID: 22874425
[TBL] [Abstract][Full Text] [Related]
18. The Hexosamine Biosynthesis Pathway: Regulation and Function.
Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
[TBL] [Abstract][Full Text] [Related]
19. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Phillips RM; Lam C; Wang H; Tran PT
Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
[TBL] [Abstract][Full Text] [Related]
20. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
Lam C; Low JY; Tran PT; Wang H
Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]